Navigation Links
Innovative screening method identifies possible new treatment for fatal childhood disease
Date:4/18/2011

esterification is the formation of esters, fatty compounds derived from acids). The discovery of a new use for a drug already on the market is always good news, as the drug has already been tested for safety.

Sturley and his team took advantage of the fact that the gene responsible for 95% of NP-C cases has been present throughout evolution, including in the evolutionarily distant yeast. They used what is called a "synthetic lethality screen" on a yeast model of NC-P. Synthetic lethality occurs when the combination of otherwise insignificant mutations in two or more genes leads to cell death. In other words, they determined which combination of mutations was lethal to the yeast.

The cell nucleus contains proteins called histones. During histone acetylation, a group of atoms called an acetyl group is substituted for a hydrogen atom, and during histone deacetylation, it is removed. When deletion of genes responsible for histone acetylation in the yeast model led to an accumulation of lipids, the researchers hypothesized that an imbalance in histone acetylation caused NP-C disease.

They found that the majority of the 11 histone deacetylase (HDAC) genes were impaired. They then discovered that the cancer drug, an HDAC inhibitor, repaired the genes. Sturley and his team concluded that the genetic pathways that exacerbate lethality in the yeast model could be reversed in human cells, providing a novel treatment for NP-C. In short, using their "exacerbate-reverse" approach, they identified the pathways that exacerbate lethality in their yeast model and then used drugs to manipulate those pathways in the opposite direction.

The next step is to test this new use of the cancer drug on mice and, eventually, hopes Sturley, in clinical trials. Although scientific curiosity originally led Sturley to study NP-C, he is now motivated by the search for a cure. "Once you get to know some of these kids and their families," he says, "it can't be othe
'/>"/>

Contact: Ann Rae Jonas
arj2116@columbia.edu
212-305-3900
Columbia University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. UNC Lineberger scientist receives Innovative Research Grant from Stand Up to Cancer
2. Research team honored for innovative science to advance cancer research
3. Innovative technique gives vision researchers insight into how people recognize faces
4. University Hospitals Case Medical Center testing innovative heat therapy for premature ejaculation
5. Innovative International Healthcare Partnership established at Arizona State University
6. Innovative virtual reality exposure therapy shows promise for returning troops
7. 3rd international conference on innovative approaches in head and neck oncology
8. Cancer prevention expert honored for innovative tobacco research
9. Elsevier launches innovative online radiology board review product
10. UC Davis surgeons test innovative device in patient with swallowing disorder
11. Experts say direct-to-consumer genetic tests need innovative oversight
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , ... July 29, 2015 , ... Indiana is known ... is also the home of Zerorez Indianapolis, which plans to expand across the state. ... “2015 is our second full year in business and we should double our first ...
(Date:7/29/2015)... FL (PRWEB) , ... July 29, 2015 , ... ... Dermatology, is the first dermatologist in Sarasota to be chosen by the manufacturer ... , “Kybella offers the first injectable, non-invasive way to treat and eliminate double ...
(Date:7/29/2015)... ... July 29, 2015 , ... Hernia repairs have always been common and routine ... by the National Center for Health Statistics indicates that more than five million ... reported annually. While the only effective treatment for a hernia is surgery, only about ...
(Date:7/29/2015)... ... July 29, 2015 , ... ITW Dynatec, ... In her role, Powers is responsible for driving growth and innovation across ITW ... “Gina’s track record as an effective leader within the ITW community speaks for ...
(Date:7/28/2015)... , ... July 29, 2015 , ... ... executives, doctors, lawyers and other A-Listers, has evolved into a world class millionaires ... a Millionaire strives to match successful and attractive people seeking real, meaningful and ...
Breaking Medicine News(10 mins):Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 2Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3Health News:Meet a Millionaire Announces It’s Not a Sugar Daddy Site, It’s a True Millionaires Club 2
... from the patient,s leg are used to strengthen weak muscles that can ... ... 2009 -- Urologists at Beaumont Hospital ( http://www.beaumonthospitals.com ) are first in ... stem cells through a research study. The stem cells are used to ...
... portion of spring promotion WHITE PLAINS, N.Y., March 10 ... a partnership with Gap Inc. through its Give & ... research, patient education and support initiatives.LLS is one of ... during the upcoming Give & Get promotion. For three ...
... The Caryl Ehrlich Program Changes Lives with 10-Sessions for ... alternative to dieting that does work. It,s called The ... people view weight loss entirely. Instead of countless diets, ... change habits of thought and word to lose weight ...
... LLC, the industry,s premier health information exchange, ... to President and Chief Operating Officer.(Logo: ... role in health care reform, leveraging our ... health quality and efficiency," said Julie Klapstein, ...
... $3.7 Million Impact on D.C. Breast HealthWASHINGTON, March 10 ... of Susan G. Komen for the Cure(R) joined the Hon. ... the Italian Embassy to officially kick off registration for the ... Cure(R), which will be held on the Washington, D.C. National ...
... MIAMI, March 10 Karen Peterson has been ... VITAS Innovative Hospice Care(R), one of the nation,s ... position, Peterson will have oversight for the interdisciplinary ... programs located throughout the country.Peterson most recently was ...
Cached Medicine News:Health News:Beaumont Launches 1st U.S. Adult Human Stem Cell Study for Stress Urinary Incontinence 2Health News:Gap Inc., The Leukemia & Lymphoma Society Encourage Shoppers to Support Cancer-Fighting Programs 2Health News:Behavioral Approach to Weight Loss 2Health News:Availity Promotes Russ Thomas to President and Chief Operating Officer 2Health News:D.C. Mayor Fenty, Italian Ambassador Help Announce First-Ever Susan G. Komen Global Race for the Cure(R) 2Health News:D.C. Mayor Fenty, Italian Ambassador Help Announce First-Ever Susan G. Komen Global Race for the Cure(R) 3Health News:D.C. Mayor Fenty, Italian Ambassador Help Announce First-Ever Susan G. Komen Global Race for the Cure(R) 4Health News:VITAS Innovative Hospice Care(R) Names Karen Peterson Vice President and Chief Nursing Officer 2
(Date:7/29/2015)... -- According to a new market research ... & Forecasts (2015-2020) , published by Mordor Intelligence, the ... billion by the end of 2020, with ... accounting for more than 36% of the global market ... to grow at a CAGR of 44.6% during the ...
(Date:7/28/2015)... 2015  Edwards Lifesciences Corporation (NYSE: EW ), ... and hemodynamic monitoring, today reported net income for the ... per diluted share.  Adjusted net income on a non-GAAP ... compared to $0.88 per diluted share in the prior ... income was $5.09 per diluted share, which included a ...
(Date:7/28/2015)... Scripts Holding Company (Nasdaq: ESRX ) announced 2015 ... of $600.1 million, or $0.88 per diluted share.  Adjusted ... were $1.44 for the second quarter. 1  ... are validating the need for size and scale," said ... matters most is how that size and scale is ...
Breaking Medicine Technology:New Approaches and Technical Advances by Major Players Like Novartis, Merck KGaA, Pfizer, GlaxoSmithKline and Others to Elevate the Global Therapeutic Vaccines Market 2New Approaches and Technical Advances by Major Players Like Novartis, Merck KGaA, Pfizer, GlaxoSmithKline and Others to Elevate the Global Therapeutic Vaccines Market 3Edwards Lifesciences Reports Second Quarter Results 2Edwards Lifesciences Reports Second Quarter Results 3Edwards Lifesciences Reports Second Quarter Results 4Edwards Lifesciences Reports Second Quarter Results 5Edwards Lifesciences Reports Second Quarter Results 6Edwards Lifesciences Reports Second Quarter Results 7Edwards Lifesciences Reports Second Quarter Results 8Edwards Lifesciences Reports Second Quarter Results 9Edwards Lifesciences Reports Second Quarter Results 10Edwards Lifesciences Reports Second Quarter Results 11Edwards Lifesciences Reports Second Quarter Results 12Edwards Lifesciences Reports Second Quarter Results 13Edwards Lifesciences Reports Second Quarter Results 14Edwards Lifesciences Reports Second Quarter Results 15Edwards Lifesciences Reports Second Quarter Results 16Edwards Lifesciences Reports Second Quarter Results 17Edwards Lifesciences Reports Second Quarter Results 18Edwards Lifesciences Reports Second Quarter Results 19Edwards Lifesciences Reports Second Quarter Results 20Edwards Lifesciences Reports Second Quarter Results 21Edwards Lifesciences Reports Second Quarter Results 22Edwards Lifesciences Reports Second Quarter Results 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12
... NEW YORK, Oct. 6, 2011 ... research report is available in its ... Therapeutics Market to 2017 - Patent ... Negatively Impact Dyslipidemia Market Value ...
... Calif. and BARCELONA, Spain, Oct. 6, 2011 ... and Grupo Ferrer International, S.A., announced today that they ...  ADASUVE is Alexza,s lead program, based on the company,s ... is a leading pharmaceutical company in Europe with extensive ...
Cached Medicine Technology:Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 2Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 3Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 4Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 5Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 6Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 7Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 8Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 9Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 10Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 11Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 12Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 13Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 14Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value 15Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America 2Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America 3Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America 4Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America 5Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America 6Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America 7
Sinus Trocar and Cannula, 4 mm...
Cannula and irrigation extension. Overall Length 150 mm (6.25"). Light Curve....
An air-based corneal esthesiometer that can stimulate subthreshold at corneal apex in normals. Has use in determining corneal physiology, healing, etc. May have application to the measurement of norm...
Kelly Punches...
Medicine Products: